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ABSTRACT. The mouse and the rat are currently overwhelmingly preferred as laboratory animals. Surgical research 
on animals requires anesthesia and analgesia to obtain adequate immobility and to reduce stress and pain. Small rodent 
anesthesia is challenging for several reasons including the animals’ size, metabolic rate, high risk of hypothermia and dif-
ficulty in monitoring. The purpose of this study is to create an overview of the information in the anesthetic practices for 
small rodents, in particular mice and rats.
Keywords: analgesia; anesthesia; mouse; rat; surgery research; welfare
ΠΕΡΙΛΗΨΗ. Ο μυς και ο επίμυς προτιμούνται κυρίως ως ζώα εργαστηρίου σε σχέση με τα άλλα ζωικά πρότυπα. Η 
πειραματική χειρουργική απαιτεί την αναισθησία και αναλγησία των ζώων, για την εξασφάλιση επαρκούς ακινητοποίη-
σής τους, μείωσης του στρες και της αίσθησης του άλγους. Η αναισθησία στα μικρά τρωκτικά αποτελεί πρόκληση λόγω 
του μικρού μεγέθους τους, του υψηλού μεταβολικού ρυθμού τους, του κινδύνου υποθερμίας και της δυσκολίας στην 
παρακολούθηση των ζωτικών τους λειτουργιών. Ο σκοπός αυτής της μελέτης είναι η ανασκόπηση των αναισθητικών 
πρακτικών που εφαρμόζονται στα μικρά τρωκτικά και ιδιαίτερα στους μυς και επίμυς.
Λέξεις-κλειδιά: αναισθησία, αναλγησία, επίμυς, ευζωία, μυς, πειραματική χειρουργική  
Review article
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INTRODUCTION
The mouse and the rat are the most preferred lab animals according to the seventh report of 
the Statistics on the Number of Animals used for 
Experimental and other Scientific Purposes in the 
Member States of the European Union (European 
Commission, 2013), representing 75% of the total 
number. This preference is due to their small size, 
and the fact that they are easy to house, maintain 
and adapt to new surroundings, while their genetic, 
biological, and behavioral characteristics closely 
resemble those of humans, replicating many symptoms 
of their conditions (Rosenthal and Brown, 2007). 
In addition, gene targeting technology, in order to 
generate a knockout/in rodent, can be easily applied to 
investigate the genetic basis of human physiology and 
disease (Scacheri et al., 2001). 
The approach to anesthesia in surgical research 
has undergone significant changes during the last 
decade and its need and benefits have been clearly 
demonstrated (Kehlet and Dahl, 2003). For scientif-
ic quality, anesthetic techniques need to be reliable 
and safe, and the effects of the compounds used 
on the research animals must be well documented. 
Furthermore, in survival surgical studies, animals 
should recover quickly and should not to be allowed 
to suffer pain (Koch, 2006), which is highly sig-
nificant for both the animal welfare and the quality 
of the study results. In addition, due to small body 
size, high body surface area/body weight ratio and 
high metabolic rate, their mechanisms of thermo-
regulation and the efficacy of injectable agents can 
be compromised (Tremoleda et al., 2012); therefore, 
high doses of these agents are required to induce 
unconsciousness, producing also detrimental effects 
on autonomic nervous system. Based on this knowl-
edge, the veterinarian can promote humane ani-
mal-based research in the protocol review process, 
select the most appropriate anesthetic and analgesic 
agents, and provide assistance for troubleshooting 
problems (Robertson, 2001, Borchard et al., 1992).
Although the reporting of the administration 
of systemic analgesic drugs to laboratory rodents 
undergoing surgical procedures is increasing, the 
majority of papers that describe potentially painful 
procedures on laboratory rodents still do not report 
systemic analgesic administration. The absence of 
administration of analgesic agents to animals under-
going surgical procedures is against the refinement 
used to alleviate pain (Coulter C.A. et al., 2011, 
Stokes E.L. et al., 2009).
This article is a literature review of the anesthetic 
protocols in mice and rats during surgical procedures 
and it is divided in pre-operative, intra-operative and 
post-operative anaesthetic and analgesic management.
PRE-OPERATIVE MANAGEMENT
Pre-anesthetic Evaluation 
Anesthesia of small rodents is particularly chal-
lenging mainly due to hypothermia, high metabolic 
rate and the lack of reliable clinical signs of respi-
ratory and cardiovascular functions (Rembert et al., 
2004), highlighting the importance of pre-anesthetic 
evaluation. This evaluation entails a thorough clinical 
assessment of the animal and precedes the delivery of 
anesthetic care for surgery. Although the physical sta-
tus of the animals is documented during inspection, 
subsequent signs of actual disease are often discov-
ered incidentally later, during the surgical experi-
ment, anesthesia, or even after the recovery. For all of 
the above reasons, it is mandatory to ascertain, before 
the experimental study, the animals’ behavioral pat-
terns, body condition score, respiratory rate, food and 
water intake, as well as defecation, urination, absence 
of skin lesions, eyes and nose discharges, or perineal 
soiling (Cantwell, 2001). In addition, the physiologi-
cal and behavioral response to stress affects a num-
ber of biological functions and systems. If stress is 
extreme or prolonged, substantial effort is required 
to maintain a state of equilibrium and the animal 
may, even develop major cardiovascular symptoms 
(Hildebrandt et al., 2008, Rottman et al., 2003). 
Pre-operative fasting of animals is a general 
approach in surgical protocols, in order to prevent pul-
monary aspiration of stomach contents during general 
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anesthesia. Several factors can predispose to aspira-
tion of stomach contents including pregnancy, obe-
sity, difficult airways management, full stomach and 
altered gastrointestinal mobility. In theory, increased 
fasting times could lead to decreased injury if aspi-
ration occurs (Allman and Wilson, 2006); howev-
er, in rodents, this is generally deemed unnecessary 
because the emetic reflex is absent (Horn et al., 2012) 
and drinking water should be accessible until one 
hour prior to the induction of anesthesia (Luciano and 
Reale, 1992, Toth and Gardiner, 2000). Furthermore, 
in small animal practice nowadays there is a trend 
towards reducing the duration of preanesthetic fasting, 
because it does not guarantee an empty stomach and it 
lowers gastric content pH (Savvas et al., 2009).
Hypothermia is a major thermal disturbance; 
the relatively low body mass to high body surface 
ratio, combined with suppressed thermoregulatory 
mechanisms, allow the rapid escape of body heat. An 
increased risk of hypoglycemia, hydroelectrolytic and 
acid–base imbalances is also proposed, not only due 
to their size, but also to the immaturity of their ther-
moregulatory centers (Paddleford, 2000). Therefore, in 
order to prevent hypothermia, the animal should be laid 
on an insulated material, such as a clean surgical towel, 
along with circulating warm water or microwavable 
heating pad underneath to provide heat support; electric 
heating is avoided because of their irregular heating 
and potential thermal burns to the animals (Fueger et 
al., 2006). Also, it is essential to minimize soaking the 
body of the rodent during the scrubbing process and to 
avoid clipping excess hair (Bernal et al., 2009). 
Accurate weighing of the animals ensures correct 
drug dosage calculations; obese animals present an 
altered biodistribution of lipophilic agents as well as 
a high incidence of hepatic dysfunctions and therefore 
are at high anesthetic risk due to hypoventilation and 
hypoxia. On the other hand, cachectic rodents pres-
ent low plasma protein binding and might hide renal, 
hepatic, or cardiac deficiencies (Zuurbier et al., 2002). 
Additionally, age, sex, genetic and environmental 
factors, as well as inherent inter-individual variability 
contribute to anesthetic variability (Hildebrandt et al., 
2008, Ciccone and Holdcroft, 1999). The small labo-
ratory animals dehydrate much faster than other larger 
species; administration of 0.2 to 0.5 mL / 10 g body 
weight of isotonic fluids, such as 0.9% saline, warmed 
subcutaneously (Bazin et al., 2004) prior to anesthesia 
is recommended for survival procedures. 
Pre-anesthetic Medication
The three components of anesthesia are analgesia 
(pain relief), amnesia (loss of memory) and immo-
bilization. The advantages of preoperative seda-
tion and analgesia include lowered patient and staff 
stress, ease of handling, and reduction of induc-
tion and inhalant anesthetic doses, most of which 
have dose-dependent adverse effects. The choice of 
pre-operative sedative and analgesic drugs depends, 
among others, on the animal’s age, physical condi-
tion and the specific operative procedure (Flecknell, 
1996). The categories of these pharmaceutical agents 
and their effects are shown below:
Anti-cholinergics (such as atropine sulfate, gly-
copyrrolate), inhibit parasympathetic nerve impuls-
es by blocking the binding of the neurotransmitter 
acetylcholine to its receptor in nerve cells. Anti-
cholinergics are divided into three categories in 
accordance with their specific targets in the central 
and/or peripheral nervous system: anti-muscarin-
ic agents, ganglionic blockers, and neuromuscular 
blockers. Anti-cholinergics are administered selec-
tively in combination with sedatives and analgesics, 
after the pre-anesthetic clinical examination of the 
animal, and according to the determined needs of 
the individual patient, the anticipated response to the 
anesthetic medication, and the tendency to develop 
bradycardia or excessive salivation (Zuurbier et al., 
2002). The need for these actions is reduced or absent 
in rodents, eliminating the routine use of these drugs, 
while the rat rapidly metabolizes atropine due to a 
hepatic atropine esterase (Thurmon et al., 1996a).
Benzodiazepines (e.g., diazepam, midazolam 
or zolazepam) enhance the effect of the neurotrans-
mitter gamma-aminobutyric acid (GABA) at the 
GABA A receptor, resulting in sedative, hypnotic 
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mechanisms (Buitrago et al., 2008) and with minimal 
irritation when injected intramuscularly or intraperito-
neally. Disadvantages of α-2 agonists include cardio-
vascular depression (decreased heart rate, decreased 
cardiac output, and hypotension), which is controlled 
by the use of atropine or glycopyrrolate. Effects can 
be reversed using a specific antagonist, atipamezole, 
a highly selective and potent α2-antagonist that rap-
idly reverses sedation as well as other behavioral and 
physiologic effects (Vainio, 1997). Medetomidine 
is a newer compound alpha-2 receptor agonist with 
sedative and analgesic properties similar to xyla-
zine with fewer undesirable side effects, providing 
excellent anesthesia in combination with ketamine. 
Dexmedetomidine is the newest of the alpha-2 agonist 
compounds that produces enhanced sedative and anal-
gesic effects (Sinclair, 2003). 
Pre-operative Analgesia
Administering a drug that blocks painful (noci-
ceptive) input from entering the CNS before a surgi-
cal procedure attenuates the development of changes 
that manifest as increased pain at later time points 
(Kissin, 2005). Clinically, this strategy predicts not 
only less pain during the initial postoperative period, 
but also lowers the intensity of pain during the days 
after the procedure and is known as “preemptive” or 
“preventive” analgesia. The ideal goal is to prevent 
the initiation of stimulation so that central sensitiza-
tion does not occur with prolonged effects (Schofield 
and Williams, 2002) (Tables 1 & 2). 
The single most effective preemptive analgesic 
technique is local, regional or spinal infiltration and 
sensory blockade with Local Anesthetics (LA). The 
utility of local anesthetics without general anesthesia 
is not recommended due to humane concerns and 
chances of bite injury to humans (Fox et al., 2002). 
The two most useful injectable anesthetics for local 
or regional anesthesia are lidocaine and bupiva-
caine; the first has a proven fast onset of action with 
moderate duration of analgesia, is stable as a solu-
tion, and infiltrates through local tissues (Branson, 
2001). A 0.5% lidocaine block of a surgical site will 
(sleep-inducing), anxiolytic (anti-anxiety), anticon-
vulsant and muscle relaxant properties. They are 
CNS depressants, suppressing normal brain function 
without producing analgesia (Schaefer et al., 2005) 
with minimal respiratory and cardiac effects limiting 
the dosage by their ceiling effect (Flecknell, 1989). 
In general, benzodiazepines are safe and effective 
in the short-term, although in humans, cognitive 
impairments and paradoxical effects such as aggres-
sion or behavioral disinhibition occasionally occur 
(Broscheit and Kranke, 2008). In most applications, 
midazolam is preferred, as it can be injected intra-
muscularly and its action can be reversed by the 
GABA receptor antagonist Flumazenil. 
Phenothiazines (e.g., promazine, acepromazine) 
are tranquilizers resulting in depressed alertness. 
Although the mechanism of action is still unknown, 
they have potent effects on the CNS and other 
organs, producing sedation, reducing the dose of 
drugs needed for general anesthesia, but also causing 
moderate hypotension and hypothermia (Tranquilli 
et al., 2007). Moreover, the incidence of ventricular 
arrhythmias and cardiac fibrillation is reduced, espe-
cially in those induced by epinephrine (Thurmon 
et al., 1996). Analgesia is not provided, but the ani-
mal’s reaction to handling or pain via sedation and 
CNS depression is reduced (Thurmon et al., 1996); 
therefore, in painful procedures, they should not be 
used and analgesia is mandatory by other means. A 
sedative or tranquilizer must be administered when 
the animal is still in its cage and the drug must be 
allowed to take effect before move the animal to 
preparation area or operating room in order to reduce 
the animal’s stress. In mice, acepromazine is used to 
potentiate and prolong ketamine and xylazine anes-
thesia (Arras et al., 2001), posing as the first choice 
among these agents, because of its long history of 
safe use in rodents (Messiha, 1991).
Alpha2-adrenergic agonists (e.g., xylazine, deto-
midine, medetomidine, dexmedetomidine) are a class 
of agents, which selectively stimulate alpha-2 adren-
ergic receptors, which produce analgesia and reduce 
hemodynamic stress through central and peripheral 
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provide < 90 min. of local anesthesia. The latter is used for over 3 hours of analgesia, at the concen-
Drug(s)
Dose range
Route of adminis-
tration
Frequency Comments
NSAIDs*
Flunixin meglumine 2.5 mg/kg SC, IM Every 12-24 
hours
-
Carprofen 5 mg/kg SC
Every 24 hours
-
Ibuprofen 40 mg/kg diluted 
in fresh water
PO Daily in fresh 
water**
-
Ketoprofen 5 mg/kg SC Every 24 hours -
Meloxicam 1-2 mg/kg PO, SC Every 12-24 hours -
Opioids
Buprenorphine 0.05-0.1 mg/kg SC, IP Every 6-12 hours
Or for major procedures, consid-
er multi-modal analgesia with a 
NSAID (e.g. meloxicam)
Butorphanol 5 mg/kg SC Every 1-2 hours If mild, pain of short duration is anticipated
Meperidine
10–20 mg/kg
 or
0.2 mg/ml of 
Demerol HCl 
syrup in water
SC, IM
PO
Every 2-3 hours
Daily in fresh 
water**
-
Morphine 10 mg/kg SC Every 2-3 hours If severe, post-operative pain is anticipated
Pentazocine 10 mg/kg SC Every 2-4 hours
Mild to moderate pain; may devel-
op analgesic tolerance with chronic 
administration
Tramadola
20-40 mg/kg
or 1ml 5% solu-
tion in 150 mL of 
water
IP Every 12-24 hours Management of post-operative pain
Other
Acetaminophen 
(Tylenol Pediatric 
Syrup) – analgesic / 
antipyreticb
1-2 mg/ml drink-
ing water made 
fresh daily
PO Daily in fresh water **
May be appropriate for procedures 
causing mild discomfort only; effi-
cacy has been questioned in rodents
Sources: Flecknell, P.A., 2009; Schofield,C. J. & Williams, V., 2002.
a Smyj R. et al., 2013.
b Mickley, G.A. et al., 2006.
Notes: * Prolonged use may cause gastrointestinal, renal or other problems.
**Rodents may exhibit “neophobia” – always monitor for acceptance when adding medications to water or food.
Table 1: Drug Dosage –Analgesia in Mice
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should not be exceeded (Richard et al., 2008, Skarda tration of 0.25%, but a total local dose of 8 mg/kg 
Drug(s)  Dose range
Route of
administration Frequency Comments
NSAIDs *
Flunixin meglumine 2.5 mg/kg SC, IM Every 12-24 hours -
Carprofen 5 mg/kg SC, PO Every 24 hours
Oral doses may need to be increased
Ibuprofen 10-30 mg/kg PO Every 4 hours -
Ketoprofen 5 mg/kg IM, SC, PO
Every 24 hours Oral doses may need to be increased
Meloxicam 1-2 mg/kg SC, PO Every 12-24 hours -
Robenacoxib 0.25-4 mg/kg SC Every 24 hours
Opioids
Buprenorphine 0.05 mg/kg SC Every 6-8 hours If mild to moderate, pain of increased duration is anticipated
Butorphanol 2 mg/kg SC Every 1-2 hours If mild, pain of short duration is antic-ipated
Meperidine
10-20 mg/kg
 or
0.2 mg/ml of 
Demerol HCl 
syrup in water
IP, IM
PO
Every 2-3 hours
Daily in fresh 
water**
-
Morphine 10 mg/kg SC Every 2-3 hours If severe, post-operative pain is antici-pated
Pentazocine 10 mg/kg SC Every 2-4 hours
Mild to moderate pain of short duration; 
may develop analgesic tolerance with 
chronic administration
Tramadol a 5-10 mg/kg IP Every 12-24 hours Management of post-operative pain
Other
Acetaminophen 
(Tylenol Pediatric 
Syrup) – analgesic / 
antipyreticb
1-2 mg/ml 
drinking water 
made fresh daily
PO Daily in fresh water**
May be appropriate for procedures caus-
ing mild discomfort only
Sources: Flecknell, P.A., 2009; Schofield,C. J. & Williams, V., 2002.
a Smyj R et al., 2013.
b Mickley, G.A. et al., 2006.
Notes: *NSAIDs may be used as the sole analgesic agent or they may be combined to provide multi-modal analgesia. 
**Rodents may exhibit “neophobia” – always monitor for acceptance when adding medications to water or food. 
Table 2: Drug Dosage –Analgesia in Rats
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et al., 2007) (Table 3). Mainly lidocaine and to a 
lesser extent bupivacaine or counterclockwise ste-
reoisomers ropivacaine and levobupivacaine, exert 
anti-inflammatory effects by changes in the normal 
immune response (Waite et al., 2010). Epidural and 
peripheral nerve blockade (Fairbanks, 2003) tech-
niques have been widely used in experimental pain 
research utilizing mice and rats, and should be readi-
ly adaptable to clinical practice. 
Effective systemic preemptive analgesic agents 
include non-steroidal anti-inflammatory agents 
(NSAIDS) and opioids, which can be used alone or in 
combination. There are several drugs in each category 
with different durations of action, but a careful choice 
should be made, taking into account the aim of the 
experiment (Ong et al., 2005). Ketoprofen, carprofen 
and meloxicam are the most widely used NSAIDS 
(Mathews, 2000) blocking peripherally the formation 
of inflammatory mediators associated with surgi-
cal injury and centrally secondary allodynia, when 
administered one hour or more before surgery (Lee-
Parritz, 2007; Schafer, 1999). A neophobic response 
(the fear and rejection of new food) has been docu-
mented when adding drugs to water of rats, causing a 
temporary weight loss (Speth et al., 2001). The current 
recommended dose for ketoprofen and carprofen in 
rats is 5 mg/kg SQ. Dilution of ketoprofen for use in 
mice to provide accurate volumes of 0.05 ml or more 
is required; for meloxicam is 1 mg/kg PO or SC in 
rats and up to 10 mg/kg in mice. The dose interval for 
these agents has not been critically evaluated in small 
rodents, so it is implemented every 12-24 hours, as 
in other species. Ibuprofen has been recommended 
for use as a pain reliever with a wide ranging dose 
of 7.5 to 30 mg/kg (Jenkins, 1987) and, as a non-spe-
cific COX inhibitor resulting in decreased prosta-
glandin formation, it is well absorbed orally with the 
major proportion excreted in the urine and the minor 
through the stool within 24 hours of the last dose. 
Robenacoxib, is the first carboxyl, non-sulfur-con-
taining COX-2-selective inhibitor to be developed for 
use in veterinary medicine. The data demonstrate that 
robenacoxib has potent analgesic, anti-inflammatory 
and antipyretic properties. Moreover, consistent with 
its weak activity as an inhibitor of COX-1, in the rat 
the gastric and intestinal tolerability of robenacoxib 
was significantly better than that of diclofenac, which 
non-selectively inhibits both COX-1 and COX-2 (King 
et al., 2009).
Opioids are classified as alkaloids such as mor-
phine and codeine, semisynthetic opioids, such as 
hydromorphone, oxycodone and naloxone, synthet-
ic such as fentanyl, buprenorphine and tramadol 
and finally as peptide opioids such as endorphine 
and enkephaline (Pasternak, 2014). Generally, the 
use of high-dose opioid anesthetic techniques pro-
duces the minimal depression of cardiac function 
and provides protection against cardiac arrhythmias 
(Schumann et al., 1994). Fentanyl, meperidine, and 
oxymorphone are added to anesthetic regimens, 
providing substantial analgesia and reducing the 
dose of the primary anesthetic (Thurmon et al., 
1996a). Short-acting opioids enable rapid induction, 
optimal operative conditions, and quick recovery, 
with few side effects. Faster offset, easy titratabili-
ty, and decreased accumulation are particularly use-
Table 3: Recommended Dosages of Local Anesthetics
Drug(s)  Mouse  Rat
Lidocaine  1-4 mg/kg or 0.4 mL/kg of a 1% solution
4 mg/kg 
(0.4 ml/kg of 1%, solution)
Bupivacaine  - 1–2 mg/kg (0.4–0.7 ml/kg of 0.25%, solution)
Sources: Flecknell, P.A., 2009; Heard, D.J., 2004.
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ful for managing intraoperative responses during 
the maintenance of general anesthesia. Bradycardia, 
respiratory depression, excessive sedation, nausea, 
ileus and pica may be side effects (Cassidy et. al., 
2010). Buprenorphine is commonly used in mice 
and rats offering significant advantages over other 
narcotics such as longer duration of action, safe-
ty and effectiveness for 6-12 hours (Gades et al., 
2000). For procedures under anesthetics with poor 
analgesic properties, such as isoflurane, buprenor-
phine should be given at least one hour before inci-
sion (Heard, 2004). In rodents, oral administration 
of buprenorphine (0.5 mg/kg) in flavored-gelatin 
cubes is a commonly used analgesia method in lab-
oratory animal medicine (Thompson et al., 2004). 
Tramadol is based on exerting inf luence on the 
μ-opioid receptor of the patient and also on increas-
ing the activity of spinal descending inhibitory 
pathways (Ide et al., 2006 Leppert, 2009. Moreover, 
it provides postoperative pain relief comparable 
with that of pethidine and its analgesic efficacy 
can be further improved by combination with a 
non-opioid analgesic, without producing the consti-
pation and dependence seen in equianalgesic doses 
of strong opioids (Grond & Sablotzki, 2004).
INTRA-OPERATIVE MANAGEMENT
General anesthesia is a state of unconsciousness 
achieved by injection or/and inhalation of substanc-
es that induce a reversible state of unconsciousness. 
For scientific quality, anesthetic techniques need 
to be reliable, safe, and the effects of the anesthetic 
and analgesic compounds must be well documented 
(Kohn et al., 1997). 
Injectable Anesthesia
Injectable drugs can serve as the sole anesthetic 
agent, induce anesthesia before inhalation anesthe-
sia, or be used as supplement in regional anesthe-
sia. Although inhalation anesthetics are considered 
generally safer than injectable anesthetics, their use 
may be limited by a lack of equipment, facilities, 
or expertise of the anesthetists (Thurmon et al., 
1996) (Table 8). The small diameter of the airways 
and the anatomy of the oropharynx prevent routine 
endotracheal intubation in mice and rats (Flecknell, 
1996; Thurmon et al., 1996); therefore, injectable 
anesthetic agents tend to be the most preferred in 
the laboratory setting (Flecknell, 1996; Hedenqvist 
and Hellebrekers, 2003). To minimize the chance 
of drug overdose and to reduce drug-related tissue 
Advantages
•	 easy to administer
•	 accuracy over the depth of anesthesia
•	 provision of oxygen results in high oxygen concentration in the blood
Disadvantages
•	 specialized equipment is usually needed
•	 good ventilation and scavenging equipment required for the safety of personnel
•	 high cost of use
Source: Ludders J.W., 1999.
Table 8. Advantages and Disadvantages of Inhalation Anesthesia
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damage, anesthetic agents for smaller (<4 kg) labora-
tory animals may need to be diluted. Disadvantages 
of injectable anesthesia include the lack of precision 
in controlling anesthetic depth, prolonged recovery 
time, and physiologic changes such as hypotension, 
hypercapnia, and hypoxemia.
Intraperitoneal (IP) injection has been commonly 
used in laboratory mice and rats (Table 4) requiring 
minimal skill and distress (Flecknell, 1996), without 
causing lesions or sign of pain even when irritat-
ing drugs are administered (Morton et al., 2001). 
Intramuscular (IM) injection of irritant drugs (e.g. 
xylazine, ketamine) may cause swelling and lame-
ness in the injected limb, resulting in self-mutilation 
(Smiler et al., 1990); therefore, it is avoided in small 
rodents. Intravenous (IV) injection into the tail vein 
is possible with the use of a restraining cage and if 
the personnel are well experienced. 
The four critical factors to be considered when 
proposing injectable drug delivery to small labora-
tory rodents are: 1) the drug volume, 2) the site(s), 3) 
the irritant properties and 4) the method of admin-
istration. Parenteral anesthetics can be delivered 
by a single bolus injection, intermittent injection or 
continuous infusion (Waynforth, 1995). Table 5 lists 
common injectable anesthetics, combination regi-
mens and doses.
Dissociative anesthetics are (among others) ket-
amine and tiletamine. A combination of equal parts of 
tiletamine hydrochloride and zolazepam hydrochloride 
is evaluated as an injectable anesthetic for laboratory 
rodents. In low doses, ketamine provides chemical 
restraint with some analgesia, while in higher doses, 
it may provide short-term surgical anesthesia; in most 
instances, the dissociative anesthetics areused in com-
bination with other injectable agents, such as xylazine, 
providing good immobilization with some degree of 
analgesia (Swalve, 2008). In combination with mede-
tomidine, doses may need to be reduced for small 
rodents by a factor of 40-50% (Jang et al., 2009). 
Other popular injectable anesthetic agents are 
barbiturates (like pentobarbital and thiopental). 
Although pentobarbital can be administered by the 
IM route, only IV or IP administration is recom-
mended for thiopental because of its high histotox-
icity (Zutphen et al., 1993). The analgesic effect of 
pentobarbital can be enhanced by balanced anesthe-
sia with opioids, or ketamine (table 5), but recovery 
is prolonged and hypothermia, respiratory depres-
sion, and hypotension are potential complications 
(Clemmesen and Hjalgrim-Jensen, 1980). 
Tribromoethanol has been the standard anesthetic 
injectable agent in much mouse transgenic work, pro-
ducing short-term (15-20 minutes) surgical anesthesia 
with good muscle relaxation and moderate respiratory 
depression (Zeller et al., 1998). Major drawbacks to 
this agent are the fact that it is cumbersome to prepare, 
the toxic by-products if not stored properly, the sensi-
tization of some animals to subsequent exposure and 
idiosyncratic deaths in about 1% of naive mice, and the 
arguable inflammatory properties. (Zeller et al., 1998; 
Reid, 1999, Weiss & Zimmermann, 1999). 
Species Subcutaneous Intramuscular Intraperitoneal Intravenous
Mouse Scruff, 2-3 ml,
<20G
Not recommended. Can 
use quadriceps or caudal 
thigh, 0.05 ml, <23G
2-3 ml,
<21G
Lateral tail vein, 0.2 ml, 
<25G
Rat Scruff, back, 5-10 ml, 
<20G
Not recommended. Can 
use quadriceps or caudal 
thigh, 0.3 ml, <21G
5-10 ml,
<21G
Lateral tail vein, 0.5 ml, 
<23G
Source: Hawk C.T. et al., 2005
Table 4: Needle Sizes and Sites and Recommended Volumes for Injection
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Drug(s) Mouse Rat
Pentobarbital
(variable anesthetic depth)
(20-40 min. of anesthesia)
30-50 mg/kg, IP
40-50 mg/kg, IP
(20-60 min. of anesthesia)
Pentobarbital +
 Ketamine  -
20 mg/kg, IP + 
60 mg/kg, IP
Pentobarbital + Buprenorphine  - 36mg/kg, IP + 0.05 mg/kg, SC
Thiopental  30-40 mg/kg, IP 20-30 mg/kg, IP
Inactin 
(thiobutabarbital, EMTU)  - 80-100 mg/kg, IP (60-240 min. of anesthesia)
Tribromoethanol  240 mg/kg, IP (15-45 min. of anesthesia) 300 mg/kg, IP
Ketamine 
(only sedation)  80-120mg/kg, IP 80-120mg/kg, IP
Tiletamine + Zolazepam (only 
sedation)  40+80 mg/kg, IP 40+80 mg/kg, IP
Ketamine + Xylazine  80-120 mg/kg + 10-16 mg/kg, IP
 (20-40 min. of anesthesia)
80-100 mg/kg + 5-10mg/kg, IP (20-50 min. of 
anesthesia)
Ketamine + Medetomidine 
(The sex of mice and rats influ-
ences the pharmacokinetics and 
metabolism of ketamine)a
 female 75+
 1mg/kg, IP
 male 50 +
 1 mg/kg, IP
female 75+
1mg/kg, IP
male 50 +
1 mg/kg, IP
Ketamine +
Dexmedetomidine
 50-75+
 0.5-1mg/kg, IP  -
Atipamezole  (for reversal of 
Xylazine and medetomidine)  1.0 mg/kg, IP 1.0 mg/kg, IP
Yohimbine
(for reversal of Xylazine)
 1.0 – 2.0 mg/kg, 
 SC or IP
2.1 mg/kg IP, SC, or 1,05 mg/kg IP + 1,05 mg/
kg SC
Ketamine + Xylazine + 
Acepromazine 
100+10+
3 mg/kg, IP
50 mg/kg + 5 mg/kg + 1 mg/kg, IP (30-45 min-
utes of anesthesia)
Ketamine + Acepromazine 100 + 5 mg/kg, IP (sedation) 75 +2.5 mg/kg, IP
Ketamine + Diazepam 100+5 mg/kg, IP 75-90+2.5-5 mg/kg, IP (in same syringe)
Ketamine + Midazolam 100+5 mg/kg, IP
100+3 mg/kg, IP
50+3 mg/kg, IP
75-90+4-5 mg/kg, IP  
(in same syringe)
Morphine 10 mg/kg, SC 2–10 mg/kg, SC
Meperidine 20 mg/kg, SC -
Fentanyl 0.06 mg/kg, SC 0.3 mg/kg, IP
Fentanyl + medetomidine Fatal 300μ g/kg + 300 μg/kg, IP
Buprenorphine 0.05-0.1 mg/kg, SC 0.01 - 0.05 mg/kg, SC or IP
Naloxone 0.01-0.05 mg/kg, IV, IM 0.01-0.1 mg/kg, IV, IM, or IP
Sources: Flecknell, P.A., 2009; Schofield,C. J. & Williams, V., 2002.; Hawk C.T. et al., 2005
a Hildebrandt et al., 2008.
Table 5: Common drugs and drug combinations used in Injectable Anesthesia for Mice and Rats
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Inhalant Anesthesia
Inhalant anesthesia can be induced by an anes-
thetic chamber (NRC, 2011; Hau & Van Hoosier, 
2003; Murray et al., 2000) or a face mask (Balafas 
et al., 2011), (Figure 1) and maintained using a 
face mask or an endotracheal tube (Kastl et al., 
2004; Papastefanou et al., 2014) (Figure 2). To pre-
vent unwanted exposure of personnel to anesthetic 
vapors or waste gases, a method of ‘scavenging’ or 
removing the waste gases must be in place.
Inhalants are halogenated hydrocarbons (halo-
thane), halogenated ethers (isoflurane, enflurane, 
desflurane, sevoflurane), or inorganic gases (N2O). 
Inhaled anesthetics have a greater margin of safety, 
producing a more stable plane of surgical anesthe-
sia, when used with a calibrated vaporizer, than 
injectable anesthetics. Since these anesthetics enter 
and leave the body through the respiratory system, 
the partial pressure of the anesthetic in the blood 
and brain can be changed immediately, thus easily 
adjusting the depth of anesthesia (Steffey, 1996; 
Brunson, 1997). Furthermore, animals undergoing 
inhalation anesthesia benefit from the fact that 
oxygen is most commonly used as the carrier gas, 
which improves tissue oxygenation. Most volatile 
agents are mainly eliminated by the lungs and 
undergo very little biotransformation, typically 
interfering only to a small extent with the liver 
function and metabolism of other drugs, which is 
especially important in pharmacology and toxicol-
ogy research (Steffey, 1996). Minimum alveolar 
concentration (MAC) is a concept used to compare 
the efficiency or strength of anesthetic vapors and 
corresponds to the effective dose of an injectable 
anesthetic (Table 6) (Joo et al., 2001), depicting 
the concentration that produces immobility in 50% 
of subjects during noxious stimulation. MAC val-
ues are higher in neonates and decrease with age, 
but induction time may be prolonged (Hau et al., 
2003). 
All inhalant anesthetics depress cardiopulmo-
nary function and renal blood flow in a dose-de-
pendent manner (Steffey, 1996). The most popu-
lar inhalation anesthetics for laboratory animals 
include nitrous oxide and the halogenated com-
pounds, halothane, isof lurane, and sevof lurane 
(Table 7). The utility and humane acceptability 
of CO2 and O2 combination as an anesthetic is an 
area of contention. Some studies have found that 
low concentrations (50% CO2) lead to prolonged 
induction and severe and frequent adverse effects 
that include nasal bleeding, excessive salivation, 
seizures, and even death. This combination is used 
for extremely short-term procedures (Murray et 
al, 2000; Kohler I. et al., 1999). Much better anes-
thetic options are available for anesthesia of longer 
duration today.
Halothane is a potent volatile anesthetic agent, 
used frequently in the past. Although it produces 
good surgical anesthesia and muscle relaxation, it is 
a strong cardiovascular and respiratory depressant; 
moreover, it has been shown to be mutagenic and 
hepatotoxic in humans after repeated and prolonged 
exposure (Kohn et al., 1997). 
Figure 1. Face mask (Low Cost Face mask, BRFAA), Balafas, E. et al., 2011. Figure 2. Materials for endotracheal intubation in 
small rodents. Papastefanou, A.et al., 2014.
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Isoflurane is generally the inhalant anesthetic 
agent of choice in mice and rats, based on its rapid 
induction and recovery with high personnel safety 
profile, and low sensitization of the myocardium 
to catecholamines. Isoflurane is also used as a sole 
anesthetic agent, enabling animal manipulation 
and injection, blood collection and minor surgical 
procedures. Induction and emergence “delirium,” 
respiratory depression, a dose-dependent hypoten-
sion, immune depression, delayed growth, and cleft 
palate in litters whose mothers have been exposed to 
this anesthetic are potential side effects (Kohn et al., 
1997, Mazze et al., 1985).
Sevoflurane can provide faster induction and 
recovery compared to isof lurane, but also caus-
es respiratory depression and hypotension in a 
dose-dependent manner (Kohn et al., 1997). It also 
appears to be better tolerated by mice and rats 
during face mask and chamber induction because of 
its low pungency and low airway irritability. Since 
it is less potent than isoflurane, the doses used are 
usually higher than those used for isoflurane and 
can be individualized based on the animal response 
(Mantziaras et al., 2004). However, recent reports 
are depicting that isoflurane and sevoflurane provide 
an equally reliable anesthesia in laboratory mice 
(Nicholls et al., 2010).
Desflurane physical properties are equal to those 
of sevoflurane, with the exception that the very low 
boiling point of desflurane makes the use of a heated 
Drugs Route Oxygen (L/min)
Concentration for 
induction (%)
Concentration
for maintenance (%)
Halothane
Mask, or chamber, or 
intubation 0.8-1 4-5 1-2
Isoflurane
Mask, or
 chamber, or intubation 0.8-1 4-5 1-3
Sevoflurane
Mask, or chamber, or 
intubation 0.8-1
6 or
Individualized, based 
on the response
 2.3-4.6 or
Individualized, based 
on the response
Desfluranea
Mask, or chamber, or 
intubation 0.8-1
6 or
Individualized, based 
on the response
 2.3-4.6 or
Individualized, based 
on the response
Sources: Flecknell, P.A., 2009; Fish R.E. et al., 2011.
aGraham, S.G., 1994.
Species Halothane  Isoflurane  Sevoflurane N2O Desflurane
a
Mouse  0.96–1.0  1.35–1.41  2.5 150–275  6.2- 9.12
Rat  0.81–1.23  1.17–1.52  2.4–2.5 155–235  5.7-7.1 
Sources: Flecknell, P.A., 2009; Fish R.E. et al., 2011.
a Mantziaras, G.I. et al., 2004.
Table 6: % MAC Values in Laboratory Mouse and Rat
Table 7: Recommended Dosages of Inhalation Anesthesia in Mice and Rats
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vaporizer necessary for controlled delivery (Hau et 
al., 2003). The lower solubility contributes to the 
rapid recovery from anesthesia compared with other 
volatile agents (Gong et al, 1998). On a cellular 
level, synaptic activity recovers more quickly in the 
hippocampus of rats subjected to normal anesthet-
ic doses of desflurane, improving both anesthetic 
and oxygen delivery to pulmonary compromised 
patients (Dimalculangan et al., 2006). Like sevoflu-
rane, the required MAC of desflurane is inversely 
related to the age of the anesthetized small rodent, 
with neonates requiring a much higher MAC than 
adults (Fish et al., 2008). 
 Nitrous oxide is a gas with good analgesic 
action, and minimal depressant effects on the respi-
ratory and cardiovascular system; it is useful in 
animals with a body weight over 2 kg, it is a weak 
anesthetic and thus it is not generally used at least 
on its own in small laboratory animals (NRC, 1984). 
POST-OPERATIVE MANAGEMENT
 Post-operative anesthetic care is a critical phase 
of anesthesia that includes a continuation of patient 
support and monitoring. After the procedure, the 
animal should be placed in a warm and quiet envi-
ronment, where lighting should ref lect the day/
night light cycle that is appropriate for the species 
(NRC, 1996b). Hypothermia is probably the single 
most important cause of anesthetic mortality in 
mice (Flecknell, 1993), therefore thermal support is 
critical to the successful recovery, such as a warm 
cage with bed or pad surface and supplied with sup-
plemental heat as required. However, all materials 
should be suitable to prevent wound contamination. 
The overriding principle that seems to work most 
efficiently is to prevent heat loss rather than to treat 
it once it occurs (Cantwell, 2001).
Animals should be minimally handled, placed 
alone in recovery caging to avoid fighting or canni-
balism and also non-ambulatory rodents should be 
separated from ambulatory animals. Dehydration 
can be treated by the administration of appropri-
ate fluid therapy, initially 1 to 2 ml of warm fluids 
(0.9% NaCl or equivalent) per 100 grams of body 
weight, by subcutaneous injection. If blood loss 
occurred during the surgical procedure, or if the 
animal is slow to recover from anesthesia, addi-
tional fluids should be provided. Mortality has been 
shown to decrease significantly in mice receiving 
0.9% sodium chloride prior to recovery from anes-
thesia (Flecknell, 1993, Smith et al., 1999). Five to 
seven days after surgery, the general condition of 
the animal must be monitored; during the post-op-
erative period, limited weight loss is observed, but 
with proper analgesia and the provision of food, 
body weight returns to normal levels (Hoff et al., 
2006). 
The post-operative analgesic management should 
minimize both the acute postoperative pain, and 
the rebound hyperalgesia, and have long-term 
effects. Post-operatively, mice and rats should be 
bright, alert, and active; interacting normally with 
cage mates, eating and drinking. Animals that are 
depressed, anorectic, or lethargic should be thor-
oughly examined (e.g. untreated pain or infection).
CONCLUSION
Anesthesia includes more than the selection 
of anesthetic drugs. A comprehensive individu-
alized anesthetic plan will minimize peri-opera-
tive morbidity and optimize peri-operative condi-
tions. Monitoring the ability to discern normal from 
abnormal and expedient intervention are critical 
to ensure that potentially reversible problems do 
not become irreversible. According to the aims of 
the surgical research, anesthetic protocol should 
be tailored by the use of tranquilizers, injectable/
inhalation anesthetics and analgesics. Continued 
improvements in anesthetic regimens for laboratory 
mice and rats are an important implementation of 
Russell and Birch’s “3 R’s” (Russell, 1959), both for 
improvement of animal health and welfare and for 
the quality of experimental procedures results.
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